This is just a small sampling of ingredient names found in our system in our CBD skincare category:
We’re always here for ingredients that show our skin love and care! As mentioned earlier, make sure you read the product information carefully. Check out our CBD Skincare category in-app to find CBD and hemp-infused products. Some of our favorites are linked below.
Hemp Seed Oil, even without Cannabinoids, is purported to reduce inflammation, hydrate, and regulate oil production. According to some dermatologists, the omega fatty acids in Hemp Seed Oil help repair skin and keep moisture locked in. One study supports this hypothesis as well, demonstrating antimicrobial, anti-inflammatory, and collagen-promoting effects of Hemp Seed extracts. Hemp Oil, an oil extracted from the whole hemp plant, has also been shown to have potential antioxidant and antibacterial properties, in addition to providing moisture without clogging pores. Hemp or Cannabis extracts have shown similar effects in studies.
The majority of these ingredient terms used in skincare, however, are ambiguous at best. “Full Spectrum” Hemp Seed Oil, despite having no official meaning, generally refers to an oil that contains many of the active cannabinoids found in the cannabis/hemp plant, excluding CBD and THC. “Full Plant” refers to the same idea, essentially just a term invented to mean that you’re getting the “full benefits” of the hemp plant. This includes elements like cannabinoids, fatty acids, terpenes, vitamins, and more. Just to make things even more confusing, Full Spectrum Hemp Oil (not Hemp Seed Oil) is a blanket term for all Hemp Oils and it can also contain CBD. Hemp Seed Oil, and Hemp Oil, can also contain very low levels of cannabinoids. Full spectrum CBD oil may contain trace amounts of THC (not enough for you to feel any psychoactive effects), but broad spectrum typically has no THC. If you find that wildly confusing, you are not alone.
CBD has been subject to considerable scientific investigation for its potential neurological and therapeutic benefits, to treat disorders like anxiety, depression, and psychosis. CBD has also proved a potentially effective treatment for skin disorders like Psoriasis and Atopic Dermatitis, additionally helping with scarring resulting from these conditions.
A. No. Based on available evidence, FDA has concluded that THC and CBD products are excluded from the dietary supplement definition under section 201(ff)(3)(B) of the FD&C Act [21 U.S.C. § 321(ff)(3)(B)]. Under that provision, if a substance (such as THC or CBD) is an active ingredient in a drug product that has been approved under section 505 of the FD&C Act [21 U.S.C. § 355], or has been authorized for investigation as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, then products containing that substance are excluded from the definition of a dietary supplement. FDA considers a substance to be “authorized for investigation as a new drug” if it is the subject of an Investigational New Drug application (IND) that has gone into effect. Under FDA’s regulations (21 CFR 312.2), unless a clinical investigation meets the limited criteria in that regulation, an IND is required for all clinical investigations of products that are subject to section 505 of the FD&C Act.
Hemp seeds are the seeds of the Cannabis sativa plant. The seeds of the plant do not naturally contain THC or CBD. The hemp seed-derived ingredients that are the subject of these GRAS notices contain only trace amounts of THC and CBD, which the seeds may pick up during harvesting and processing when they are in contact with other parts of the plant. Consumption of these hemp seed-derived ingredients is not capable of making consumers “high.”
While the agency is aware of reports of pets consuming various forms of cannabis, to date, FDA has not directly received any reports of adverse events associated with animals given cannabis products. However, adverse events from accidental ingestion are well-documented in scientific literature. If you feel your animal has suffered from ingesting cannabis, we encourage you to report the adverse event to the FDA. Please visit Reporting Information about Animal Drugs and Devices to learn more about how to report an adverse event related to an animal drug or for how to report an adverse event or problem with a pet food.
Information from adverse event reports regarding cannabis use is extremely limited; the FDA primarily receives adverse event reports for approved products. General information on the potential adverse effects of using cannabis and its constituents can come from clinical trials that have been published, as well as from spontaneously reported adverse events sent to the FDA. Additional information about the safety and effectiveness of cannabis and its constituents is needed. Clinical trials of cannabis conducted under an IND application could collect this important information as a part of the drug development process.
There is an exception to section 201(ff)(3)(B) if the substance was “marketed as” a dietary supplement or as a conventional food before the drug was approved or before the new drug investigations were authorized, as applicable. However, based on available evidence, FDA has concluded that this is not the case for THC or CBD.
But that hasn’t stopped retailers from touting the benefits of CBD in dog treats, vape pens, lotions, lip balms, lozenges, and oils. Some products made with CBD are available legally in some states where medical marijuana is not. On the medicinal front, one promising CBD-based medicine — designed to treat a rare form of epilepsy — is currently in development and awaiting approval from the US Food and Drug Administration.
I knew I’d arrived in California when a friend offered me an edible — for my dog.
The future of cannabis-based medicines
Given CBD’s unclear legal framework, it’s important to be cautious when purchasing items containing the ingredient. It’s also helpful to know that marijuana isn’t just composed of CBD and THC — it has some 400 different compounds, each of which may be responsible for a distinct effect.
The treat didn’t contain THC, the component of marijuana that’s responsible for getting you high. Instead, it was made with cannabidiol, or CBD, a non-psychoactive compound in marijuana that may potentially be useful for a range of therapeutic applications. The research on this front remains in its infancy, but thanks to a wave of developments into new cannabis-based drugs, it’s an exciting time to keep an eye out for new research.
Only one drug made with cannabis-derived ingredients has clearance from the FDA. That drug is dronabinol, which treats some of the negative side effects of chemotherapy and AIDS, such as nausea, loss of appetite, and weight loss . It is made using lab-produced versions of THC, the main psychoactive ingredient in marijuana, and is available with a doctor’s prescription.